In a remarkable breakthrough for stem cell research, a team of Australian scientists from Magellan Stem Cells has been celebrated globally for their pioneering work in osteoarthritis clinical research. These researchers have received the esteemed Research Publication of the Year Award from a
The development of SENTI-202, which leverages engineered chimeric antigen receptor natural killer (CAR NK) cells, signifies a significant advancement in the treatment landscape for relapsed or refractory acute myeloid leukemia (AML). Presented at the American Association for Cancer Research Annual
In recent developments within the biopharmaceutical sector, DuPont has taken a significant step forward by unveiling its latest offering. The introduction of Liveo Pharma TPE Ultra-Low Temp Tubing marks an innovative expansion of DuPont's product line, specifically targeted at the stringent
Parkinson's disease, a progressive and degenerative brain condition, affects more than 1 percent of individuals over the age of 60 worldwide, leading to symptoms such as slow movements, muscle tremors, stiffness, and difficulty walking. Traditional treatments focus primarily on managing
With over 300 million people globally suffering from chronic hepatitis B, the disease presents a monumental challenge in the realm of public health. Traditional treatments have mainly focused on suppressing the virus rather than providing a cure, demanding lifelong therapy for many patients.
Ivan Kairatov is a distinguished figure in the biopharma industry, renowned for his expertise in tech and innovation within the field. With a robust background in research and development, Ivan has substantially influenced advancements in cellular therapies and drug development. Today, we delve
